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The function of the kidney with its highly differentiated and
specialized cell types is affected by infection with several
viruses. Viral infections of the kidney have a negative impact
not only on patients undergoing renal transplantation and
immunosuppression. Besides the increasing number of
patients suffering from HIV-associated nephropathy, another
group of viruses infects immunocompetent patients and
induces renal failure. Hantaviruses belong nowadays to the
emerging zoonoses that increase in number and geographic
distribution. The viruses are distributed worldwide in
endemic areas and distribution seems to expand. Together
with the increase in the number of cases in the last few years,
the understanding of epidemiology and pathology has
deepened and some concepts had to be changed. Symptoms
and mortality vary between species. The classification refers
to geographical distribution: New World hantaviruses
causing hantavirus cardiopulmonary syndrome (HCPS) and
Old World hantaviruses causing hemorrhagic fever with
renal syndrome (HFRS). Indeed, in most HFRS cases, the
kidney is mainly affected and HCPS is characterized by
cardiopulmonary involvement. But the picture of strict organ
tropism is changing and reports of pulmonary findings
and nonrenal manifestations in infections with Old
World hantaviruses are increasing. However, the overall
symptoms—vascular alterations and leakage—that are
responsible for organ failure are characteristic for all diseases
caused by hantaviruses.
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Hantaviruses mostly represent rodent-borne pathogens that
infect different cell types and affect organ function.1
Infections comprise respiratory and renal illnesses ranging
from subclinical, mild, and severe courses to fatal outcome.
Moreover, some species are nonpathogenic to humans. Both
virus- and patient-specific determinants are responsible
for this heterogeneity in diseases caused by hantaviruses.
Infection with pathogenic hantaviruses leads to the
deterioration of the highly specialized and differentiated
endothelial cell types, resulting in the loss of barrier function
of the vasculature. Cellular damage can be induced by
physical and chemical stress or infection. In hemorrhagic
fever with renal syndrome (HFRS), the clinical picture is
characterized by acute renal failure with often massive
proteinuria caused by tubular and glomerular involvement.
The mechanism of kidney injury during infection is not fully
understood. In the last few years, interdisciplinary research
aspects of epidemiology, virology, and nephrology provided
useful insights in the pathology of diseases caused by these
emerging viruses.
VIROLOGY
Despite heterogeneous clinical pictures and different
host reservoirs, hantaviruses have similar genomic organiza-
tion, and RNA-encoded proteins share high levels
of sequence homology.2 Hantaviruses constitute the genus
Hantavirus in the family Bunyaviridae.3 Similar to
other bunyaviruses, they are enveloped negative-stranded
RNA viruses with a tripartite genome. Large (L), medium
(M), and small (S) RNA segments encode, respectively, the
viral RNA-dependent RNA-polymerase (the L protein), a
precursor for two surface glycoproteins, Gn and Gc, and the
nucleocapsid (N) protein. In some hantaviruses, the S
segment encodes also a nonstructural protein NS, which
acts as an interferon antagonist.4 Genetic diversity in
hantaviruses is generated by genetic drift, reassortment of
genome RNA segments, and recombination.5 Genetic drift
occurs through accumulation of point mutations (through
the genome) and small insertions/deletions (in the
noncoding regions). Reassortment of genome RNA
segments seems to occur much more frequently than
recombination.6
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EPIDEMIOLOGY
Peculiar distribution of rodent host species has led to specific
geographical pattern of hantaviruses and associated diseases.
In Eurasia, hantaviruses cause HFRS of various severity. In
Asia, the list of hantavirus pathogens includes Hantaan,
Seoul, and Amur-Soochong viruses, which affect mostly
China, South Korea, and the far-eastern region of Russia.7,8
In Europe, in addition to the above-mentioned Seoul virus,
Puumala, Dobrava-Belgrade, Saaremaa, and Tula viruses are
found, often in co-circulation.7,9 Endemic area includes
northern and central Europe (Denmark, Finland, Norway,
Sweden, Belgium, Chech Republic, France, Germany, and
Slovakia), Alpe-Adrian region (Austria, Croatia, Hungary,
and Slovenia), the Balkans (Albania, Greece), and the
European part of Russia. Sin Nombre, Andes, and related
viruses such as New York, Bayou, Laguna Negra, Choclo, Rio
Mamore, Araraquara, Castelo dos Sonhos viruses cause
hantavirus cardiopulmonary syndrome (HCPS) in the
Americas (Argentina, Bolivia, Brazil, Canada, Chile,
Panama, Paraguay, Uruguay, and USA). Naturally, both
lists—for the viruses and for the countries—are incomplete
and it is safe to assume that they will get longer in the nearest
future.
Currently, 23 distinct hantaviruses species have been
recognized; the list of provisional species includes 30
viruses.10 Recently, we have been witnessing an ‘explosion’
in a number of newly discovered hantaviruses that was
started by publication of Klempa et al.,11 who designed
remarkably efficient, generic PCR primers for the recovery of
partial hantaviral L segment sequences. Recently, the first
indigenous African hantavirus (Sangassou virus) was
isolated, and a retrospective seroepidemiological analysis
revealed the presence of Sangassou virus-specific neutralizing
antibodies in the sera of patients suffering from fever of
unknown origin.12 Besides the detection of new hantaviruses
in rodents, other small mammals such as shrews, moles,
and bats were captured and identified as reservoir hosts
of hantaviruses. The epidemiological importance of these
hantaviruses remains to be evaluated. The knowledge
of hantaviruses as viruses of broader host range and
identification of possible new human pathogens increase
the number of populations that may be affected by
hantavirus infection.
Epidemiological studies also try to identify risk factors
for severe courses. The male-to-female ratio for hantavirus
disease varies from 2 to 5:1. Interestingly, though the
prevalence of HCPS and HFRS is higher among males
than females, the case fatality ratio is higher for women in
HCPS, HFRS, and nephropathia epidemica (NE).13–15
Besides gender, several clinical parameters have been
analyzed as predictors for the clinical course. The
study of Rasche et al. and our own observations (Figure 1)
in cohorts of patients with NE demonstrate that a low
platelet count (o60G/l) precedes severe acute renal
failure indicated as rise in serum creatinine levels
(4620 mmol/l).16
CLINICAL ASPECTS
As the first description of New World hantaviruses, the
differences in the clinical pictures were emphasized.17 It was a
clear-cut picture of New World hantaviruses causing HCPS
and Old World hantaviruses causing HFRS. Indeed, most
European and Asian cases of hantavirus infection fit well in
this scheme and are characterized by acute renal failure.
However, in the last few years, reports of hantavirus cases
with divergent symptomatology increased in quantity. Cases
of hantavirus infection with pulmonary involvement were
observed in Europe, and acute renal failure occurs in patients
infected with New World hantaviruses.18,19 Today we are
dealing with hantavirus infection as an intriguing event with
a unique range of symptoms and the intensity of presenting
symptoms for each individual is also unique.
Hantavirus infections, HCPS and HFRS, are characterized
by sudden onset with flu-like symptoms, such as fever,
headache, abdominal pain, and nausea, followed by a
hypotensive phase with often severe thrombocytopenia and
increased vascular permeability, leukocytosis, elevated levels
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Figure 1 | Nadir level of platelet count is predictive for severe
renal failure. Course of serum creatinine levels (a) and platelet
counts (b) in patients with milder or severe acute renal failure during
nephropathica epidemica (NE). Mean values and s.d. are shown. Mean
values of mild cases were compared with those of severe courses
using Student’s t-test (*Po0.05; **Po0.01; ***Po0.0001). Levels of
platelets increased significantly faster in milder than in severe courses
of NE. In milder courses, platelets reached values of the lower limit of
the reference range (150–440G/l) within the first week after illness
onset, whereas in severe courses platelet counts at day 5 and 6 were
still very low. Interestingly, creatinine levels up to day 6 after the
onset of symptoms were equal, and although milder courses then
showed a continuous decrease, creatinine levels increased suddenly
at day 7 in severe courses.
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of lactate dehydrogenase, and C-reactive protein. After this
phase, the infection manifests in different organs. HCPS is
a predominantly cardiopulmonary disease in which renal
symptoms may be observed as well. In contrast, in most
cases, HFRS affects predominantly kidney function. Labora-
tory findings in HFRS and NE demonstrate high-serum
creatinine and low-serum albumin, and urinalysis shows
hematuria and albuminuria. This oliguric phase with acute
renal failure is followed by the diuretic phase in which renal
function improves and the convalescent phase during which
patients recover completely. Acute renal failure is observed in
90–95% of infections with Old World hantaviruses. The long-
term prognosis of NE caused by Puumala virus is favorable
and most patients fully recover renal function. However,
hypertension is discussed to be a long-term consequence of
Puumala virus infection.20 Although mortality rate for NE is
o1%, case fatality rate for HFRS ranges from 5 to 15% and
up to 50% for HCPS. Severity is mainly determined by the
hantavirus species that causes the disease, but it also varies
individually from subclinical presentation to fatality.
Cardiogenic shock due to respiratory failure is responsible
for the often fatal outcome of HCPS. Death due to HFRS
maybe because of several complications: renal insufficiency,
edema and hemorrhages, encephalopathy, or shock. Signs
and symptoms of hantavirus infection may present
differently and can affect different organs.21,22
Serological tests for the detection of IgM and IgG
antibodies based on indirect immunofluorescence assays,
strip immunoblot, or enzyme-linked immunosorbent assays
are commercially available and are commonly used for
diagnosis. IgM response starts with the onset of symptoms, is
early detectable, and indicates acute infection. Patients
develop antibodies that recognize hantaviral structural
proteins: the envelope glycoproteins (Gn, Gc) and the
nucleocapsid proteins (N protein). Serological tests detect
antibodies specific for the N protein. Identification of the
infecting hantavirus species by these methods is often not
reliable because of cross-reactivity of antihantavirus anti-
bodies. Reverse transcription PCR with specific primers
detects viral genomes in blood or tissue specimens and allows
the differentiation between hantaviruses species. Viral RNA
in blood samples is detectable only after the onset of
symptoms. In this phase, viral RNA may be detected before
IgM antibodies are present.23 However, later after onset,
reverse transcription PCR is not applicable for diagnosis
because of short or low-level viremic status of patients.
Therefore, the diagnosis should occur on the basis of clinical
symptoms together with a serological confirmation.24
As no specific antiviral medication is available, the
treatment of infection is limited to supportive therapy. The
nucleoside analog, ribavirin, reduces mortality in HFRS, but
the usefulness in HCPS patients is still controversial. New
strategies for vaccination and treatment are currently under
investigation. The effects of vaccines based on recombinant
hantaviral antigens, virus-like particles, or transfer of
adenoviral vectors expressing hantaviral proteins were
studied in animal models and clinical trials. Furthermore,
steps of the viral replication cycle were explored as potential
therapeutic targets: peptides and small molecules, which
block viral receptors or drugs that inhibit the increase of
endothelial permeability.25 The understanding of hantaviral
pathogenesis is a prerequisite for the development of such
specific antiviral strategies.
PATHOGENESIS
In addition to the observation that gender may influence the
risk for specific symptoms and fatal outcome, certain human
leukocyte antigen (HLA) haplotypes were identified to be
associated with milder or severe courses.26–28 Therefore,
the frequency of severe courses in endemic areas may be
dependent on the genetic susceptibility by the prevalence of
certain HLA genes in the population. Furthermore, the
association between HLA alleles and severity implies an
involvement of T-cell-mediated effects in hantavirus
pathogenesis. High counts of specific CD8þ cells were
observed in severe cases of HPS and in HFRS patients.29,30
The absence of obvious endothelial damage in biopsies
suggests that barrier breakdown is caused by the release of
cytokines rather than by endothelial cell death. Endothelial
function is regulated by a complex interplay between
endothelial cells with platelets and immune cells. In
noninflamed state, endothelial cells regulate permeability,
quiesce leukocytes, and inhibit activation of platelets.
Infection of endothelial cells leads to activation of signaling
pathways, induction of proinflammatory chemokines, and
recruitment of immune cells at the site of inflammation.
The inflammatory response leads to the activation of the
complement system and the secretion of multiple proin-
flammatory cytokines that interfere with endothelial function
and induce leakage of proteins. Cytokines in humans during
hantavirus infection include tumor necrosis factors, interleukins,
interferons, colony-stimulating factors, and transforming
growth factors (summarized in Safronetz et al.31). It is still
unclear which cytokines have a critical role in the capillary
leakage in hantavirus diseases.
Another subset of T cells—regulatory T cells (Treg)—is
downregulated in hantavirus infection in humans and
upregulated in rodents.32–35 Treg cells mediate suppression
of immune response and may therefore be beneficial in
infection by limiting the immunopathogenesis. The
downregulation of Treg cells in hantavirus infection of
humans may result in enhanced immune-mediated tissue
damage. In contrast, the upregulation of Treg cells
contributes to the manifestation of hantaviral persistence in
rodents.
MOLECULAR PATHOGENESIS
Neither viral pathogenicity factor(s) nor determinants for
organ manifestation responsible for the clinical picture have
been identified so far. The clinical symptoms were elicited by
vascular leakage. The control of endothelial barrier function
is complex and makes the understanding of the molecular
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pathogenesis difficult, and research is hampered by the lack
of an adequate small animal model. Data from human blood
samples and biopsies, infected rodent reservoir species, cell
culture, and monkey models suggest pathomechanisms,
which are based on direct effects by viral replication and
indirect damage caused by the overreacting immune system.
Different cell types have been identified to be permissive for
hantavirus infection: endothelial, epithelial cells of different
organs, and several immune cells (monocytes, macrophages,
dendritic cells).36,37 Dendritic cells residing in the respiratory
tract become infected and may facilitate hantaviral spread to
endothelial cells of distant organs.
Hantaviral entry in target cells is mediated by integrins
and CD55.38,39 Interestingly, pathogenic and nonpathogenic
hantaviruses differ in the use of integrin receptors:
pathogenic hantaviruses enter through beta 3 integrins,
whereas nonpathogenic hantaviruses utilize beta 1 integrin.
As beta 3 integrins function in angiogenesis and regulation of
vascular permeability, the use as entry receptor may
contribute to the disease.40 Upon entry, viral replication
and spread take place. Pathogenic hantaviruses exert a
delayed induction of interferon response, facilitating initial
viral spread that leads afterward to enhanced damage due to a
stronger immune response. High viral RNA copy numbers
correlate with low platelet counts, and the mean viral load
in fatal cases is higher than in survivors.41 However, viral
replication does not result in any gross cytopathic effects
causing cell death, but changes of subcellular structures
leading to cellular dysfunction were observed. Tight and
adherens junctions are specialized multiprotein complexes
that are crucial for the endothelial and epithelial barrier
function. Studies in vitro and in biopsy samples of
hantavirus-infected patients demonstrate the disruption
of cell-to-cell contacts and its correlation with the severity
of clinical picture (Figure 2).39 The mechanism of disruption
of cell-to-cell contacts is not known. Barrier breakdown may
be mediated directly by infection and/or by secretion
of cytokines involved in the regulation of permeability.
In vitro studies demonstrate, that hantavirus-infected
endothelial cells are sensitized to the induction of
permeability by vascular endothelial growth factor and
demonstrate enhanced internalization of E-cadherin.42
Identification of the signaling pathways that are disturbed
by hantavirus infection provides possible options for antiviral
therapeutic strategies.
CONCLUSION
To draw a comprehensive picture of molecular pathogenesis is
still difficult. Severe hantavirus infections are multifactorial
diseases involving both patient- and virus-specific determi-
nants. Several factors have been identified so far that influence
the clinical course, such as gender, HLA haplotype, viral load,
cytokine levels, and T-cell response. Analysis of the underlying
molecular pathomechanisms revealed that hantavirus infec-
tion impairs the integrity of cell-to-cell contacts. This loss
of endothelial barrier function may be mediated by altered
signaling pathways involving integrin, vascular endothelial
growth factor, and E-cadherin. Increasing case numbers that
are associated with host reservoirs and influenced by climatic
conditions and the broad range and variance of symptoms,
whose molecular mechanisms are not yet completely under-
stood, make the hantavirus one of the emerging zoonoses that
will require the attention of a multidisciplinary research. At
present, the lack of vaccines and a specific antiviral therapy
render the prevention of infection as the only way to decrease
the emergence of hantavirus cases. Closer attention in
endemic areas is needed for the control of mice in and
outside houses and for the prevention of contact with
contaminated aerosols. Furthermore, increased awareness of
hantavirus infection should be given by a medical practitioner
early in the diagnosis of flu-like symptoms with acute renal
failure and thrombocytopenia.
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